Post-streptococcal glomerulonephritis primary prevention
|
Post-streptococcal glomerulonephritis Microchapters |
|
Differentiating Post-streptococcal glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Post-streptococcal glomerulonephritis primary prevention On the Web |
|
American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis primary prevention |
|
FDA on Post-streptococcal glomerulonephritis primary prevention |
|
CDC on Post-streptococcal glomerulonephritis primary prevention |
|
Post-streptococcal glomerulonephritis primary prevention in the news |
|
Blogs on Post-streptococcal glomerulonephritis primary prevention |
|
Directions to Hospitals Treating Post-streptococcal glomerulonephritis |
|
Risk calculators and risk factors for Post-streptococcal glomerulonephritis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Effective measures for the primary prevention of post-streptococcal glomerulonephritis include improving hand hygiene, better housing, prevent overcrowding, treatment of an infected patient within 24 hours with antibiotics and prevent close contact. A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.
Primary Prevention
- Effective measures for the primary prevention of post-streptococcal glomerulonephritis include:
- Spread of group A streptococcal infection should be reduced by following methods:[1][2][3][4]
- Improving hand hygiene
- Better housing
- Prevent overcrowding
- Treatment of infected patient within 24 hours with antibiotics
- Prevent close contact
- Spread of group A streptococcal infection should be reduced by following methods:[1][2][3][4]
- A 26-valent vaccine is recommended for children to prevent post-streptococcal glomerulonephritis.[5]
References
- ↑ "Group A Strep | Post-Streptococcal Glomerulonephritis | For Clinicians | GAS | CDC".
- ↑ Johnston F, Carapetis J, Patel MS, Wallace T, Spillane P (1999). "Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis". Pediatr Infect Dis J. 18 (4): 327–32. PMID 10223684.
- ↑ Rodríguez-Iturbe B, Rubio L, García R (1981). "Attack rate of poststreptococcal nephritis in families. A prospective study". Lancet. 1 (8217): 401–3. PMID 6110037.
- ↑ Rodriguez-Iturbe B, Musser JM (2008). "The current state of poststreptococcal glomerulonephritis". J Am Soc Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.
- ↑ Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B (July 2005). "Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes". Clin. Diagn. Lab. Immunol. 12 (7): 833–6. doi:10.1128/CDLI.12.7.833-836.2005. PMC 1182208. PMID 16002631.